MENU

IRD Opus Genetics Inc Forecast, Technical & Fundamental Analysis

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders... Show more

IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
IRD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics

Industry Biotechnology

Profile
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HILCX27.990.29
+1.05%
Hartford International Value C
LINRX24.340.24
+1.00%
Lord Abbett International Opp R3
FMQSX17.180.15
+0.88%
Franklin Mutual Quest R
SMDGX12.850.08
+0.63%
American Funds U.S. Sm & Md Cp Eq C
HDPBX30.360.13
+0.43%
Hodges Blue Chip Equity Income Retail

IRD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IRD has been loosely correlated with ARRY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IRD jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRD
1D Price
Change %
IRD100%
-1.70%
ARRY - IRD
35%
Loosely correlated
-0.42%
IMUX - IRD
35%
Loosely correlated
+2.48%
PRME - IRD
35%
Loosely correlated
+4.63%
ROIV - IRD
35%
Loosely correlated
-1.47%
EDIT - IRD
31%
Poorly correlated
+5.78%
More
Opus Genetics (IRD) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com